alemtuzumab
sanofi
['alemtuzumab', 'hlb']
for those interested in #bmfsm two posters being presented tomorrow evening at #eha2022. looked at outcomes in #saa patients receiving #covid19 vaccine and reports long-term results of our alemtuzumab study for relapsed saa. 
???????????Haematologist @nih_nhlbi l @ucdmedicine @trinitymed1 l Lover of ????????l #SAA #IBMFS #telomeres #CHIP #MDS #AML #HSCT #VEXAS l Comments mine.